Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.AuthorsBerenson, James; Manges, Robert; Badarinath, Suprith; Cartmell, Alan; McIntyre, Kristi; Lyons, Roger; Harb, Wael; Mohamed, Hesham; Nourbakhsh, Ali; Rifkin, RobertPublicationAmerican Journal of Hematology, 2017, Vol 92, Issue 5, p460ISSN0361-8609Publication typeArticleDOI10.1002/ajh.24687